Anvil Diagnostics
anvildiagnostics.com
Actively hiring
Biotechnology
Molecular Diagnostics
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Launchpad Venture Group
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Launchpad Venture Group Similar startupsby what they do, their industry and backers
Smartcatch is lifting the current locks on CTC liquid biopsy by developing a range of compact, portable, easy-to-use products that can…
RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid…
En Carta Diagnostics develops molecular tests, as easy to use as rapid tests, as precise as a PCR machine. We currently offer Lyme disease…
Electrosurgery, liquid suction, smoke evacuation, and blunt dissection in one single-use surgical device.
Expanding PCR testing to a whole new range of conditions. Making precision diagnostics accessible around the planet. Our technology…
Programmable advanced therapies. Our technology allows gene control based on cell identity, ensuring only the target cell population is…
Overview
Anvil Diagnostics develops MycoScan™, a rapid 3-hour pan-fungal liquid biopsy for invasive fungal infections using proprietary SKIP-Seq™ technology.